Ganciclovir Sodium



Indications and Reactions:

Role Indications Reactions
Primary
Glioma 21.6%
Cytomegalovirus Infection 12.3%
Antifungal Prophylaxis 8.8%
Drug Use For Unknown Indication 7.6%
Prophylaxis 6.1%
Product Used For Unknown Indication 5.8%
Prophylaxis Against Transplant Rejection 4.4%
Idiopathic Thrombocytopenic Purpura 4.1%
Crohn's Disease 3.5%
Immunosuppression 3.5%
Prophylaxis Against Graft Versus Host Disease 3.2%
Hiv Infection 2.6%
Lymphoproliferative Disorder 2.6%
Diffuse Large B-cell Lymphoma 2.3%
T-cell Lymphoma 2.3%
Antiviral Prophylaxis 2.0%
Colitis Ulcerative 2.0%
Epstein-barr Virus Infection 1.8%
Polyarteritis Nodosa 1.8%
Cytomegalovirus Colitis 1.5%
Cytomegalovirus Infection 10.4%
Death 9.1%
Aspergillosis 7.8%
Pancytopenia 7.8%
Tumour Lysis Syndrome 7.8%
Renal Impairment 6.5%
Diabetic Hyperosmolar Coma 5.2%
Hydrocephalus 5.2%
Thrombocytopenia 5.2%
Bone Marrow Failure 3.9%
Neutropenia 3.9%
Renal Failure 3.9%
Status Epilepticus 3.9%
Ulcer 3.9%
Blood Creatinine Increased 2.6%
Epilepsy 2.6%
Hemiparesis 2.6%
Lung Transplant Rejection 2.6%
Mycobacterium Avium Complex Immune Restoration Disease 2.6%
Neutrophil Pelger-huet Anomaly Present 2.6%
Secondary
Cytomegalovirus Infection 13.0%
Product Used For Unknown Indication 12.4%
Prophylaxis Against Transplant Rejection 9.3%
Plasmablastic Lymphoma 7.3%
Prophylaxis 6.7%
Immunosuppression 5.7%
Acquired Immunodeficiency Syndrome 4.9%
Drug Use For Unknown Indication 4.7%
Hiv Infection 4.7%
Infection Prophylaxis 4.4%
Crohn's Disease 4.1%
Prophylaxis Against Graft Versus Host Disease 3.6%
Lymphoproliferative Disorder 3.4%
Pyrexia 3.1%
Atrial Fibrillation 2.3%
Stem Cell Transplant 2.3%
Antifungal Prophylaxis 2.1%
Idiopathic Thrombocytopenic Purpura 2.1%
Pneumonia 2.1%
Antiretroviral Therapy 1.8%
Multi-organ Failure 9.1%
Renal Impairment 7.8%
Thrombotic Microangiopathy 7.8%
Bone Marrow Failure 6.5%
Pancytopenia 6.5%
Transplant Rejection 6.5%
Mycobacterium Avium Complex Immune Restoration Disease 5.2%
Neutropenia 5.2%
Petit Mal Epilepsy 5.2%
Pneumonia Cytomegaloviral 5.2%
Renal Failure 5.2%
Respiratory Failure 5.2%
Bone Marrow Toxicity 3.9%
Nephropathy Toxic 3.9%
Thrombocytopenia 3.9%
Acute Respiratory Distress Syndrome 2.6%
Aplasia 2.6%
Blood Creatinine Increased 2.6%
Cytomegalovirus Chorioretinitis 2.6%
Cytomegalovirus Colitis 2.6%
Concomitant
Immunosuppression 16.2%
Product Used For Unknown Indication 12.7%
Prophylaxis 12.7%
Hiv Infection 8.1%
Liver Transplant 6.1%
Pneumocystis Jiroveci Pneumonia 5.7%
Diabetes Mellitus 4.8%
Stem Cell Transplant 4.1%
Gastrointestinal Disorder 3.9%
Vitamin Supplementation 3.5%
Antiretroviral Therapy 3.1%
B-cell Lymphoma 3.1%
Upper Respiratory Tract Infection 2.6%
Pain 2.4%
Pulmonary Tuberculosis 2.2%
Candidiasis 2.0%
Premedication 2.0%
Mineral Supplementation 1.7%
Prophylaxis Against Gastrointestinal Ulcer 1.7%
Prophylaxis Against Transplant Rejection 1.5%
Osteonecrosis 11.1%
Respiratory Failure 8.9%
Urinary Tract Infection 8.9%
Aids Encephalopathy 4.4%
Duodenitis 4.4%
Dysphagia 4.4%
Herpes Zoster 4.4%
Liver Disorder 4.4%
Overdose 4.4%
Pharmaceutical Product Complaint 4.4%
Pneumonia Cytomegaloviral 4.4%
Pulmonary Oedema 4.4%
Renal Tubular Necrosis 4.4%
Status Epilepticus 4.4%
Systemic Inflammatory Response Syndrome 4.4%
Toxic Encephalopathy 4.4%
Transplant Failure 4.4%
Venoocclusive Liver Disease 4.4%
Abdominal Pain 2.2%
Bronchitis Bacterial 2.2%